GAPDHP56: A Drug Target / Disease Biomarker (G100421232)

Target Name: GAPDHP56

NCBI ID: G100421232

GAPDHP56

Other Name(s): Glyceraldehyde 3 phosphate dehydrogenase pseudogene 56 | glyceraldehyde 3 phosphate dehydrogenase pseudogene 56

GAPDHP56: A Drug Target / Disease Biomarker

GAPDHP56 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the cell division process, and its levels have been linked to the development and progression of many diseases. As a drug target or biomarker, GAPDHP56 has potential for use in the treatment of a wide range of conditions.

GAPDHP56 is a member of the GTPase-activating protein (GAP) family. This family of proteins is known for their ability to regulate the assembly and disassembly of RNA molecules, which are involved in gene expression and other cellular processes. GAPDHP56 is a 21-kDa protein that is expressed in a variety of tissues, including muscle, heart, liver, and brain.

One of the key functions of GAPDHP56 is its role in cell division. During cell division, GAPDHP56 helps to regulate the formation of new cells and the separation of these cells from each other. This is important for the growth and development of tissues and for the maintenance of tissue homeostasis.

In addition to its role in cell division, GAPDHP56 has also been shown to be involved in the regulation of many other cellular processes. For example, GAPDHP56 has been shown to be involved in the regulation of protein synthesis, DNA replication, and cell signaling. It has also been shown to play a role in the regulation of cell adhesion and in the development of cancer.

GAPDHP56 has also been shown to be a potential drug target or biomarker in a variety of diseases. For example, GAPDHP56 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the development of cancer, and may be a useful biomarker for the detection of cancer.

In addition to its potential use as a drug target or biomarker, GAPDHP56 has also been shown to have potential as a therapeutic agent. For example, studies have shown that GAPDHP56 can be expressed in neurons and may have neuroprotective effects. Additionally, GAPDHP56 has been shown to be involved in the regulation of many cellular processes, making it a potential target for small molecules that can modulate these processes.

Overall, GAPDHP56 is a protein that has the potential to be a drug target or biomarker in a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective therapies based on its properties.

Protein Name: Glyceraldehyde 3 Phosphate Dehydrogenase Pseudogene 56

The "GAPDHP56 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAPDHP56 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets